Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials

• Main Authors: Junlong Zhuang (Author), Yuwen Wang (Author), Shun Zhang (Author), Yao Fu (Author), Haifeng Huang (Author), Xiaoyu Lyu (Author), Shiwei Zhang (Author), Giancarlo Marra (Author), Linfeng Xu (Author), Xuefeng Qiu (Author), Hongqian Guo (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: The study aimed to compare the efficacy and safety of androgen deprivation therapy (ADT) with abiraterone or docetaxel versus ADT alone as neoadjuvant therapy in patients with very-high-risk localized prostate cancer.Methods: This was a pooled analysis of two single-center, randomized, co...